The NurOwn platform from BrainStorm (New York City) makes use of human mesenchymal stem cells, which are derived from a patient’s own bone marrow, to treat neurological diseases. The cells have the capacity for self-renewal and differentiation into various tissues.
|
|
Scooped by
TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
onto #ALS AWARENESS #LouGehrigsDisease #PARKINSONS March 31, 2012 8:32 PM
|
Your new post is loading...